Revolutionary Cancer Vaccine Targets All Solid Tumors
The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...
Nature29d
How macrophage–drug conjugates are transforming solid-tumor cell therapy
Cellis is preparing to take its lead candidate into the clinic after seeing durable complete remissions in solid-tumor models. Drug developers have struggled to translate the exceptional efficacy ...
A Simple Blood Test Could Detect the Most Common Cancer in Young Men
Researchers have validated a specific cluster of microRNAs (miRNAs) as reliable biomarkers for detecting malignant testicular ...
Sportschosun on MSN2d
Development of a precise prediction model for prognosis and survival rate of colorectal cancer liver metastasis patients with AI
Korean researchers have developed an artificial intelligence (AI) model that can accurately predict the prognosis and ...
Leaving unmeasurable data out of mathematical models for tumor growth can produce inaccurate results
Mathematical models for predicting how cancer tumors in mice grow over time can give distorted results if unmeasurable data ...
technologynetworks7d
Optimizing Cell Culture Models To Mimic the Tumor Microenvironment
The complexity of the TME in vivo limits the conclusions that can be drawn from in vitro models of cancer progression and therapy response. Optimizing cell culture models to mimic the TME is vital to ...
Precision Medicine Online1d
Cero Therapeutics Advancing Autologous Cell Therapy to Phase I Solid Tumor Trials
The firm previously said it will test the CER T-cell therapy CER-1236 in blood cancers after receiving FDA manufacturing clearance.
Aptevo Therapeutics provides overview of APVO603 targeting 4-1BB, OX40
Aptevo Therapeutics (APVO) provided an overview of solid tumor anti-cancer compound APVO603, currently in preclinical development for the ...
Business Wire29d
Laekna Announces IND Approval of LAE120 (a Novel USP1 Inhibitor) for Treatment of Advanced Solid Tumors by FDA
LAE120 shows robust tumor inhibitory activity across various xenograft models such as MDA-MB-436 and ... ovarian cancer and PD-1/ PD-L1 drug-resistant solid tumors. LAE002 (afuresertib) is a ...